Innovative Clinical Trials: The LUNG-MAP Study
Steuer, C E, Papadimitrakopoulou, V, Herbst, R S, Redman, M W, Hirsch, F R, Mack, P C, Ramalingam, S S, Gandara, D R
Published in Clinical pharmacology and therapeutics (01.05.2015)
Published in Clinical pharmacology and therapeutics (01.05.2015)
Get more information
Journal Article
The effect of the UGT1A128 allele on survival after irinotecan-based chemotherapy: a collaborative meta-analysis
Dias, M M, Pignon, J-P, Karapetis, C S, Boige, V, Glimelius, B, Kweekel, D M, Lara, P N, Laurent-Puig, P, Martinez-Balibrea, E, Páez, D, Punt, C J A, Redman, M W, Toffoli, G, Wadelius, M, McKinnon, R A, Sorich, M J
Published in The pharmacogenomics journal (01.10.2014)
Published in The pharmacogenomics journal (01.10.2014)
Get full text
Journal Article
EGFR High Copy Number Together With High EGFR Protein Expression Predicts Improved Outcome for Cetuximab-based Therapy in Squamous Cell Lung Cancer: Analysis From SWOG S0819, a Phase III Trial of Chemotherapy With or Without Cetuximab in Advanced NSCLC
Hirsch, Fred R., Redman, Mary W., Moon, James, Agustoni, Francesco, Herbst, Roy S., Semrad, Thomas J., Varella-Garcia, Marileila, Rivard, Chris J., Kelly, Karen, Gandara, David R., Mack, Philip C.
Published in Clinical lung cancer (01.01.2022)
Published in Clinical lung cancer (01.01.2022)
Get full text
Journal Article
Acquired Resistance to Targeted Therapies Against Oncogene-Driven Non–Small-Cell Lung Cancer: Approach to Subtyping Progressive Disease and Clinical Implications
Gandara, David R, Li, Tianhong, Lara, Primo N, Kelly, Karen, Riess, Jonathan W, Redman, Mary W, Mack, Philip C
Published in Clinical lung cancer (01.01.2014)
Published in Clinical lung cancer (01.01.2014)
Get full text
Journal Article
Systematic evaluation of the impact of disease progression (DP) date determination on progression-free survival (PFS) in advanced lung cancer: A joint North Central Cancer Treatment Group (NCCTG) and Southwest Oncology Group (SWOG) investigation
Mandrekar, S. J., Qi, Y., Allen-Ziegler, K., Hillman, S. L., Redman, M. W., Schild, S. E., Gandara, D. R., Adjei, A. A.
Published in Journal of clinical oncology (20.05.2011)
Published in Journal of clinical oncology (20.05.2011)
Get full text
Journal Article
KRAS and EGFR mutations in the molecular epidemiology of NSCLC: Interim analysis of S0424
Mack, P. C., Redman, M. W., Chansky, K., Matsumoto, S., Holland, W. S., Lara, P., Ambrosone, C. B., Gandara, D. R.
Published in Journal of clinical oncology (20.05.2010)
Published in Journal of clinical oncology (20.05.2010)
Get full text
Journal Article
S0536: Carboplatin, paclitaxel, cetuximab, and bevacizumab followed by cetuximab and bevacizumab maintenance in advanced non-small cell lung cancer (NSCLC): A SWOG phase II study
Gandara, D., Kim, E. S., Herbst, R. S., Moon, J., Redman, M. W., Dakhil, S. R., Hirsch, F., Mack, P. C., Franklin, W., Kelly, K.
Published in Journal of clinical oncology (20.05.2009)
Published in Journal of clinical oncology (20.05.2009)
Get full text
Journal Article
Infectious ribonucleic acid derived from enteroviruses
SPRUNT, K, REDMAN, W M, ALEXANDER, H E
Published in Proceedings of the Society for Experimental Biology and Medicine (01.08.1959)
Published in Proceedings of the Society for Experimental Biology and Medicine (01.08.1959)
Get more information
Journal Article
Factors influencing degree of infectivity of enterovirus ribonucleic acid
SPRUNT, K, REDMAN, W M, KOENIG, S, ALEXANDER, H E
Published in Proceedings of the Society for Experimental Biology and Medicine (01.02.1960)
Published in Proceedings of the Society for Experimental Biology and Medicine (01.02.1960)
Get more information
Journal Article
Combination of Antigenic Traits of Type 1 and Type 2 Poliovirus
Sprunt, Katherine, Redman, Winifred M, Alexander, Hattie E
Published in The Journal of immunology (1950) (01.03.1959)
Published in The Journal of immunology (1950) (01.03.1959)
Get full text
Journal Article
Alternative measures predicting clinical benefit in advanced non-small cell lung cancer (NSCLC) from Southwest Oncology Group (SWOG) randomized trials: Implications for clinical trial design
Lara, P. N., Redman, M. W., Kelly, K., Edelman, M. J., Williamson, S. K., Crowley, J. J., Gandara, D. R.
Published in Journal of clinical oncology (20.06.2006)
Published in Journal of clinical oncology (20.06.2006)
Get full text
Journal Article
Abstract P4-22-11: Combined targeted therapies for advanced triple negative breast cancer: A phase II trial of nab-paclitaxel and bevacizumab followed by maintenance targeted therapy with bevacizumab and erlotinib
Specht, JM, Gadi, VK, Gralow, JR, Korde, LA, Linden, HM, Salazar, LG, Rodler, ET, Cundy, A, Buening, BJ, Baker, KK, Redman, MW, Kurland, BF, Garrison, MA, Smith, JC, vanHaelst, C, Anderson, JE
Published in Cancer research (Chicago, Ill.) (15.02.2017)
Published in Cancer research (Chicago, Ill.) (15.02.2017)
Get full text
Journal Article
Elevated osteopontin (OPN) plasma levels are highly prognostic in advanced non-small cell lung cancer (NSCLC): Analysis of SWOG S0003
Mack, P. C., Redman, M. W., Chansky, K., Williamson, S. K., Farneth, N., Lara, P. N., Le, Q., Gumerlock, P. H., Crowley, J. J., Gandara, D. R.
Published in Journal of clinical oncology (20.06.2006)
Published in Journal of clinical oncology (20.06.2006)
Get full text
Journal Article
Lung-MAP--framework, overview, and design principles
Ferrarotto, Renata, Redman, Mary W, Gandara, David R, Herbst, Roy S, Papadimitrakopoulou, Vassiliki A
Published in Chinese clinical oncology (01.09.2015)
Published in Chinese clinical oncology (01.09.2015)
Get more information
Journal Article
The long-term outcome in surviving infants with Apgar zero at 10 minutes: a systematic review of the literature and hospital-based cohort
Harrington, Deborah J., MD, Redman, Christopher W., MD, Moulden, Mary, Greenwood, Catherine E., MD
Published in American journal of obstetrics and gynecology (01.05.2007)
Published in American journal of obstetrics and gynecology (01.05.2007)
Get full text
Journal Article